Aurobindo’s Generic of Xanax XR Approved by FDA

June 15, 2011, 10:06 PM UTC

The Food and Drug Administration June 7 approved Aurobindo Pharma Ltd.’s generic alprazolam extended-release tablets, a generic of Xanax XR, the company announced in a June 8 statement.

Aurobindo Pharma Ltd.’s newly approved generic of alprazolam is used, like Xanax XR, to treat patients who have panic disorder, either with or without agoraphobia. The company said it will provide the drug in 0.5 mg, 1 mg, 2 mg, and 3 mg strengths, just like the reference drug, which is a Pfizer product.

Aurobindo will manufacture and market the alprazolam, which it expects will be launched soon in the United States, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.